10/02/2025
When collaboration meets innovation, the possibilities are limitless. 🤝✨ We're proud to join the AstraZeneca BioVentureHub in Gothenburg, working side-by-side to accelerate breakthroughs in chromatography, molecular genomics, proteomics, and more. Together, we're creating a connected ecosystem that helps life-changing medicines reach patients faster.
What happens when R&D teams come together?
We’re joining the AstraZeneca BioVentureHub in Gothenburg, Sweden, where a Thermo Fisher team will work side-by-side with AstraZeneca scientists on collaborative projects, with a focus in chromatography, molecular genomics, proteomics and more. This open innovation model is designed to speed smarter drug and analytical development for emerging biotechs, academic groups, and, ultimately, patients.
“When two global life science leaders join forces in an open innovation environment, truly exceptional conditions for breakthrough discovery and progress are created,” said Magnus Björsne, CEO, AstraZeneca BioVentureHub.
The BioVentureHub sits next to GoCo Health Innovation City in Gothenburg, future home of Thermo Fisher’s newest bioanalytical laboratory. This proximity will create a connected ecosystem where ideas move faster from concept to clinic, supported by our global lab network.
Together, we’re building the conditions for discovery so customers can bring life-changing medicines to patients sooner. Explore more at the link in comments.
